Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spyre Therapeutics, Inc. | 500,000 | reported | 23 Feb 2023 | tx 2+630,000 |
| ArriVent BioPharma, Inc. | 130,000 | reported | 02 Feb 2026 | tx 2+232,000 |
| Viela Bio, Inc. | 0 | reported | 15 Mar 2021 | tx 2+50,000−50,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | GRANT_AWARD | ArriVent BioPharma, Inc. | 130,000 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | ArriVent BioPharma, Inc. | 102,000 | 0.00 USD | deriv |
| 23 Feb 2023 | GRANT_AWARD | Spyre Therapeutics, Inc. | 500,000 | 0.00 USD | deriv |
| 23 Aug 2022 | GRANT_AWARD | Spyre Therapeutics, Inc. | 130,000 | 0.00 USD | deriv |
| 15 Mar 2021 | OTHER | Viela Bio, Inc. | 50,000 | — | deriv |
| 14 Jan 2020 | GRANT_AWARD | Viela Bio, Inc. | 50,000 | 0.00 USD | deriv |